{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,20]],"date-time":"2026-11-20T18:03:52Z","timestamp":1795197832997,"version":"4.10.3"},"reference-count":118,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Dermatol Surg","DS"],"published-print":{"date-parts":[[2017,1]]},"abstract":"<jats:sec>\n                    <jats:title>BACKGROUND<\/jats:title>\n                    <jats:p>Keloid and hypertrophic scars represent an aberrant response to the wound healing process. These scars are characterized by dysregulated growth with excessive collagen formation, and can be cosmetically and functionally disruptive to patients.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>OBJECTIVE<\/jats:title>\n                    <jats:p>Objectives are to describe the pathophysiology of keloid and hypertrophic scar, and to compare differences with the normal wound healing process. The classification of keloids and hypertrophic scars are then discussed. Finally, various treatment options including prevention, conventional therapies, surgical therapies, and adjuvant therapies are described in detail.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>MATERIALS AND METHODS<\/jats:title>\n                    <jats:p>Literature review was performed identifying relevant publications pertaining to the pathophysiology, classification, and treatment of keloid and hypertrophic scars.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>RESULTS<\/jats:title>\n                    <jats:p>Though the pathophysiology of keloid and hypertrophic scars is not completely known, various cytokines have been implicated, including interleukin (IL)-6, IL-8, and IL-10, as well as various growth factors including transforming growth factor-beta and platelet-derived growth factor. Numerous treatments have been studied for keloid and hypertrophic scars,which include conventional therapies such as occlusive dressings, compression therapy, and steroids; surgical therapies such as excision and cryosurgery; and adjuvant and emerging therapies including radiation therapy, interferon, 5-fluorouracil, imiquimod, tacrolimus, sirolimus, bleomycin, doxorubicin, transforming growth factor-beta, epidermal growth factor, verapamil, retinoic acid, tamoxifen, botulinum toxin A, onion extract, silicone-based camouflage, hydrogel scaffold, and skin tension offloading device.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>CONCLUSION<\/jats:title>\n                    <jats:p>Keloid and hypertrophic scars remain a challenging condition, with potential cosmetic and functional consequences to patients. Several therapies exist which function through different mechanisms. Better understanding into the pathogenesis will allow for development of newer and more targeted therapies in the future.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1097\/dss.0000000000000819","type":"journal-article","created":{"date-parts":[[2016,6,26]],"date-time":"2016-06-26T04:32:19Z","timestamp":1466915539000},"page":"S3-S18","source":"Crossref","is-referenced-by-count":588,"title":["Keloids and Hypertrophic Scars: Pathophysiology, Classification, and Treatment"],"prefix":"10.1097","volume":"43","author":[{"given":"Brian","family":"Berman","sequence":"first","affiliation":[{"name":"Department of Dermatology and Cutaneous Surgery, University of Miami Miller School of Medicine, Miami, Florida;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Maderal","sequence":"additional","affiliation":[{"name":"Dermatology Resident, University of Miami Miller School of Medicine, Miami, Florida;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brian","family":"Raphael","sequence":"additional","affiliation":[{"name":"Micrographic Surgery and Dermatologic Oncology, SkinCare Physicians, Chestnut Hill, Massachusetts"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-20230814","doi-asserted-by":"crossref","first-page":"1358","DOI":"10.1160\/TH04-03-0146","article-title":"Effect of activated platelets on expression of cytokines in peripheral blood mononuclear cells\u2014potential role of prostaglandin E2","volume":"92","author":"Waehre","year":"2004","journal-title":"Thomb Haemost"},{"key":"R2-20230814","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1007\/s00403-009-1020-0","article-title":"p38 MAPK-regulated EGFR internalization takes place in keratinocyte monolayer during stress conditions","volume":"302","author":"Lambert","year":"2010","journal-title":"Arch Dermatol Res"},{"key":"R3-20230814","doi-asserted-by":"crossref","first-page":"484","DOI":"10.2353\/ajpath.2007.061092","article-title":"Delayed and deficient dermal maturation in mice lacking the CXCR3 ELR-negative CXC chemokine receptor","volume":"171","author":"Yates","year":"2007","journal-title":"Am J Pathol"},{"key":"R4-20230814","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1111\/j.1524-475X.2007.00273.x","article-title":"db\/db mice exhibit severe wound-healing impairments compared with other murine diabetic strains in a silicone-splinted excisional wound model","volume":"15","author":"Michaels","year":"2007","journal-title":"Wound Repair Regen"},{"key":"R5-20230814","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1006\/cyto.1999.0598","article-title":"Diminished interleukin 6 (IL-6) production during scarless human fetal wound repair","volume":"12","author":"Liechty","year":"2000","journal-title":"Cytokine"},{"key":"R6-20230814","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1111\/exd.12739","article-title":"Suppressed inflammatory gene expression during human hypertrophic scar compared to normotrophic scar formation","volume":"24","author":"van den Broek","year":"2015","journal-title":"Exp Dermatol"},{"key":"R7-20230814","doi-asserted-by":"crossref","first-page":"866","DOI":"10.1053\/jpsu.2000.6868","article-title":"Fetal wound repair results in scar formation in interleukin-10-deficient mice in a syngeneic murine model of scarless fetal wound repair","volume":"35","author":"Liechty","year":"2000","journal-title":"J Pediatr Surg"},{"key":"R8-20230814","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1111\/j.1365-4632.2010.04678.x","article-title":"Strategies for prevention of scars: what can we learn from fetal skin?","volume":"50","author":"Namazi","year":"2011","journal-title":"Int J Dermatol"},{"key":"R9-20230814","doi-asserted-by":"crossref","first-page":"1122","DOI":"10.1016\/S0960-9822(03)00396-8","article-title":"Wound healing in the PU.1 null mouse\u2013tissue repair is not dependent on inflammatory cells","volume":"13","author":"Martin","year":"2003","journal-title":"Curr Biol"},{"key":"R10-20230814","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1002\/dvg.1020140309","article-title":"Rapid induction and clearance of TGF beta 1 is an early response to wounding in the mouse embryo","volume":"14","author":"Martin","year":"1993","journal-title":"Dev Genet"},{"key":"R11-20230814","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1016\/S0094-1298(20)32476-7","article-title":"The problem scar","volume":"25","author":"Su","year":"1998","journal-title":"Clin Plast Surg"},{"key":"R12-20230814","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.1242\/jcs.107.5.1137","article-title":"Neutralising antibody to TGF-beta 1,2 reduces cutaneous scarring in adult rodents","volume":"107","author":"Shah","year":"1994","journal-title":"J Cell Sci"},{"key":"R13-20230814","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1242\/jcs.108.3.985","article-title":"Neutralisation of TGF-beta 1 and TGF-beta 2 or exogenous addition of TGF-beta 3 to cutaneous rat wounds reduces scarring","volume":"108","author":"Shah","year":"1995","journal-title":"J Cell Sci"},{"key":"R14-20230814","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.1016\/S0002-9440(10)65364-3","article-title":"Role of elevated plasma transforming growth factor-beta1 levels in wound healing","volume":"154","author":"Shah","year":"1999","journal-title":"Am J Pathol"},{"key":"R15-20230814","doi-asserted-by":"crossref","first-page":"1316","DOI":"10.1006\/bbrc.2001.4257","article-title":"Upregulation of HSP47 and collagen type III in the dermal fibrotic disease, keloid","volume":"280","author":"Naitoh","year":"2001","journal-title":"Biochem Biophys Res Commun"},{"key":"R16-20230814","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1006\/jsre.1993.1132","article-title":"Regulation of collagen gene expression in keloids and hypertrophic scars","volume":"55","author":"Friedman","year":"1993","journal-title":"J Surg Res"},{"key":"R17-20230814","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1002\/bdrc.21016","article-title":"Elastin signaling in wound repair","volume":"96","author":"Almine","year":"2012","journal-title":"Birth Defects Res C Embryo Today"},{"key":"R19-20230814","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1046\/j.1524-4725.1999.08292.x","article-title":"Comparison of a silicone gel-filled cushion and silicon gel sheeting for the treatment of hypertrophic or keloid scars","volume":"25","author":"Berman","year":"1999","journal-title":"Dermatol Surg"},{"key":"R20-20230814","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD003826.pub3","article-title":"Silicone gel sheeting for preventing and treating hypertrophic and keloid scars","author":"O'Brien","year":"2013","journal-title":"Cochrane Database Syst Rev"},{"key":"R21-20230814","doi-asserted-by":"crossref","first-page":"1246","DOI":"10.1002\/hep.21792","article-title":"Transforming growth factor-beta and substrate stiffness regulate portal fibroblast activation in culture","volume":"46","author":"Li","year":"2007","journal-title":"Hepatology"},{"key":"R22-20230814","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1002\/jcp.20274","article-title":"Extracellular matrix rigidity governs smooth muscle cell motility in a biphasic fashion","volume":"204","author":"Peyton","year":"2005","journal-title":"J Cell Physiol"},{"key":"R24-20230814","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1007\/s00266-008-9152-8","article-title":"Intralesional triamcinolone acetonide for keloid treatment: a systematic review","volume":"32","author":"Hochman","year":"2008","journal-title":"Aesthetic Plast Surg"},{"key":"R25-20230814","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1097\/PRS.0b013e3181c82dd5","article-title":"The most current algorithms for the treatment and prevention of hypertrophic scars and keloids","volume":"125","author":"Ogawa","year":"2010","journal-title":"Plast Reconstr Surg"},{"key":"R26-20230814","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1111\/j.1524-4725.2012.02345.x","article-title":"A new uniform protocol of combined corticosteroid injections and ointment application reduces recurrence rates after surgical keloid\/hypertrophic scar excision","volume":"38","author":"Hayashi","year":"2012","journal-title":"Dermatol Surg"},{"key":"R27-20230814","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1111\/j.1524-4725.2011.02137.x","article-title":"Comparison of the efficacy of intralesional triamcinolone acetonide and 5-fluorouracil tattooing for the treatment of keloids","volume":"38","author":"Sadeghinia","year":"2012","journal-title":"Dermatol Surg"},{"key":"R28-20230814","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1016\/S0190-9622(97)70113-0","article-title":"Recurrence rates of excised keloids treated with postoperative triamcinolone acetonide injections or interferon alfa-2b injections","volume":"37","author":"Berman","year":"1997","journal-title":"J Am Acad Dermatol"},{"key":"R29-20230814","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1177\/014556139407301010","article-title":"Ear lobe keloids, surgical excision followed by radiation therapy: a 10-year experience","volume":"73","author":"Chaudhry","year":"1994","journal-title":"Ear Nose Throat J"},{"key":"R30-20230814","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1111\/j.1524-4725.1996.tb00376.x","article-title":"Prevention of earlobe keloid recurrence with postoperative corticosteroid injections versus radiation therapy: a randomized, prospective study and review of the literature","volume":"22","author":"Sclafani","year":"1996","journal-title":"Dermatol Surg"},{"key":"R31-20230814","doi-asserted-by":"crossref","first-page":"1164","DOI":"10.1097\/scs.0b013e3180de62a1","article-title":"Combined surgical excision and radiation therapy for keloid treatment","volume":"18","author":"Akita","year":"2007","journal-title":"J Craniofac Surg"},{"key":"R32-20230814","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1111\/j.1365-2230.1982.tb02434.x","article-title":"The historical and scientific basis of cryosurgery","volume":"7","author":"Shepherd","year":"1982","journal-title":"Clin Exp Dermatol"},{"key":"R33-20230814","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1111\/j.1524-475X.2005.00084.x","article-title":"Intralesional cryosurgery enhances the involution of recalcitrant auricular keloids: a new clinical approach supported by experimental studies","volume":"14","author":"Har-Shai","year":"2006","journal-title":"Wound Repair Regen"},{"key":"R34-20230814","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1097\/DSS.0000000000000417","article-title":"Keloid removal by shave excision with adjuvant external beam radiation therapy","volume":"41","author":"Keeling","year":"2015","journal-title":"Dermatol Surg"},{"key":"R35-20230814","doi-asserted-by":"crossref","first-page":"e440","DOI":"10.1097\/GOX.0000000000000357","article-title":"Surgical excision with adjuvant irradiation for treatment of keloid scars: a systematic review","volume":"3","author":"van Leeuwen","year":"2015","journal-title":"Plast Reconstr Surg Glob Open"},{"key":"R36-20230814","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1111\/1346-8138.12702","article-title":"Ionizing irradiation inhibits keloid fibroblast cell proliferation and induces premature cellular senescence","volume":"42","author":"Ji","year":"2015","journal-title":"J Dermatol"},{"key":"R37-20230814","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1093\/jrr\/rrv031","article-title":"Hypofractionated electron-beam radiation therapy for keloids: retrospective study of 568 cases with 834 lesions","volume":"56","author":"Shen","year":"2015","journal-title":"J Radiat Res"},{"key":"R38-20230814","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1038\/nature07039","article-title":"Wound repair and regeneration","volume":"453","author":"Gurtner","year":"2008","journal-title":"Nature"},{"key":"R39-20230814","doi-asserted-by":"crossref","first-page":"20150405","DOI":"10.1259\/bjr.20150405","article-title":"Radiotherapy for benign disease; assessing the risk of radiation-induced cancer following exposure to intermediate dose radiation","volume":"88","author":"McKeown","year":"2015","journal-title":"Br J Radiol"},{"key":"R40-20230814","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/S0733-8635(05)70235-7","article-title":"The interferons","volume":"19","author":"Edwards","year":"2001","journal-title":"Dermatol Clin"},{"key":"R41-20230814","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1016\/S0190-9622(89)70239-5","article-title":"Short-term keloid treatment in vivo with human interferon alfa-2b results in a selective and persistent normalization of keloidal fibroblast collagen, glycosaminoglycan, and collagenase production in vitro","volume":"21","author":"Berman","year":"1989","journal-title":"J Am Acad Dermatol"},{"key":"R42-20230814","first-page":"152","article-title":"The molecular biology of fibroproliferative disorders of the skin: potential cytokine therapeutics","volume":"33","author":"Tredget","year":"1994","journal-title":"Ann Plast Surg"},{"key":"R43-20230814","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1006\/jsre.1995.1074","article-title":"Regulation of collagen synthesis and mRNA expression in normal and hypertrophic scar fibroblasts in vitro by interferon-gamma","volume":"58","author":"Harrop","year":"1995","journal-title":"J Surg Res"},{"key":"R44-20230814","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.1097\/00006534-199810000-00001","article-title":"Transforming growth factor-beta in thermally injured patients with hypertrophic scars: effects of interferon alpha-2b","volume":"102","author":"Tredget","year":"1998","journal-title":"Plast Reconstr Surg"},{"key":"R45-20230814","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1111\/j.1365-4362.1996.tb01671.x","article-title":"Failure of interferon-alpha 2b in the treatment of mature keloids","volume":"35","author":"al-Khawajah","year":"1996","journal-title":"Int J Dermatol"},{"key":"R46-20230814","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1111\/j.1365-4632.2008.03426.x","article-title":"Effects of interferon-alpha2b on keloid treatment with triamcinolone acetonide intralesional injection","volume":"47","author":"Lee","year":"2008","journal-title":"Int J Dermatol"},{"key":"R47-20230814","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1111\/j.1365-2230.2007.02631.x","article-title":"Intralesional triamcinolone alone or in combination with 5-fluorouracil for the treatment of keloid and hypertrophic scars","volume":"34","author":"Darougheh","year":"2009","journal-title":"Clin Exp Dermatol"},{"key":"R48-20230814","first-page":"54","article-title":"Intralesional 5-fluorouracil as a treatment modality of keloids","volume":"30","author":"Nanda","year":"2004","journal-title":"Dermatol Surg"},{"key":"R49-20230814","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1016\/j.jaad.2004.09.018","article-title":"Intralesional 5-fluorouracil in the treatment of keloids: an open clinical and histopathologic study","volume":"52","author":"Kontochristopoulos","year":"2005","journal-title":"J Am Acad Dermatol"},{"key":"R50-20230814","first-page":"778","article-title":"Intralesional 5-fluorouracil in keloid treatment: a systematic review","volume":"95","author":"Bijlard","year":"2015","journal-title":"Acta Derm Venereol"},{"key":"R51-20230814","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1097\/PRS.0b013e3181904d1b","article-title":"5-Fluorouracil treatment of problematic scars","volume":"123","author":"Haurani","year":"2009","journal-title":"Plast Reconstr Surg"},{"key":"R53-20230814","doi-asserted-by":"crossref","first-page":"5880","DOI":"10.4081\/dr.2015.5880","article-title":"The Use of Chemotherapeutics for the treatment of keloid scars","volume":"7","author":"Jones","year":"2015","journal-title":"Dermatol Rep"},{"key":"R54-20230814","first-page":"1394","article-title":"Postsurgical use of imiquimod 5% cream in the prevention of earlobe keloid recurrences: results of an open-label, pilot study","volume":"31","author":"Martin-Garcia","year":"2005","journal-title":"Dermatol Surg"},{"issue":"Suppl 66","key":"R55-20230814","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1046\/j.0366-077X.2003.05636.x","article-title":"Topical application of imiquimod 5% cream to keloids alters expression genes associated with apoptosis","volume":"149","author":"Jacob","year":"2003","journal-title":"Br J Dermatol"},{"key":"R56-20230814","doi-asserted-by":"crossref","first-page":"S209","DOI":"10.1067\/mjd.2002.126585","article-title":"Pilot study of the effect of postoperative imiquimod 5% cream on the recurrence rate of excised keloids","volume":"47","author":"Berman","year":"2002","journal-title":"J Am Acad Dermatol"},{"key":"R57-20230814","first-page":"1363","article-title":"The efficacy of 5% imiquimod cream in the prevention of recurrence of excised keloids","volume":"90","author":"Chuangsuwanich","year":"2007","journal-title":"J Med Assoc Thai"},{"key":"R58-20230814","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1111\/j.1524-4725.2009.01101.x","article-title":"Failure of imiquimod 5% cream to prevent recurrence of surgically excised trunk keloids","volume":"35","author":"Cacao","year":"2009","journal-title":"Dermatol Surg"},{"key":"R59-20230814","first-page":"455","article-title":"Treatment of keloid scars post-shave excision with imiquimod 5% cream: a prospective, double-blind, placebo-controlled pilot study","volume":"8","author":"Berman","year":"2009","journal-title":"J Drugs Dermatol"},{"key":"R60-20230814","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1111\/j.1365-2133.2012.11023.x","article-title":"FK506 inhibits the enhancing effects of transforming growth factor (TGF)-beta1 on collagen expression and TGF-beta\/Smad signalling in keloid fibroblasts: implication for new therapeutic approach","volume":"167","author":"Wu","year":"2012","journal-title":"Br J Dermatol"},{"key":"R61-20230814","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1067\/mjd.2001.117736","article-title":"Are keloids really \u201cgli-loids\u201d?: high-level expression of gli-1 oncogene in keloids","volume":"45","author":"Kim","year":"2001","journal-title":"J Am Acad Dermatol"},{"key":"R62-20230814","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1111\/j.1600-0846.2010.00479.x","article-title":"Intradermal tacrolimus prevent scar hypertrophy in a rabbit ear model: a clinical, histological and spectroscopical analysis","volume":"17","author":"Gisquet","year":"2011","journal-title":"Skin Res Technol"},{"key":"R63-20230814","first-page":"399","article-title":"An open-label pilot study to evaluate the safety and tolerability of tacrolimus ointment 0.1% for the treatment of keloids","volume":"18","author":"Berman","year":"2007","journal-title":"Cosmet Dermatol"},{"key":"R64-20230814","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1111\/j.1600-0625.2007.00550.x","article-title":"mTOR as a potential therapeutic target for treatment of keloids and excessive scars","volume":"16","author":"Ong","year":"2007","journal-title":"Exp Dermatol"},{"key":"R65-20230814","doi-asserted-by":"crossref","first-page":"23166","DOI":"10.1074\/jbc.M401238200","article-title":"Mammalian target of rapamycin positively regulates collagen type I production via a phosphatidylinositol 3-kinase-independent pathway","volume":"279","author":"Shegogue","year":"2004","journal-title":"J Biol Chem"},{"key":"R66-20230814","doi-asserted-by":"crossref","first-page":"1198","DOI":"10.1016\/S0016-5085(99)70406-3","article-title":"Rapamycin inhibits hepatic stellate cell proliferation in vitro and limits fibrogenesis in an in vivo model of liver fibrosis","volume":"117","author":"Zhu","year":"1999","journal-title":"Gastroenterology"},{"key":"R67-20230814","doi-asserted-by":"crossref","first-page":"3459","DOI":"10.1016\/j.transproceed.2005.09.066","article-title":"Sirolimus inhibits platelet-derived growth factor-induced collagen synthesis in rat vascular smooth muscle cells","volume":"37","author":"Park","year":"2005","journal-title":"Transplant Proc"},{"key":"R68-20230814","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1097\/SAP.0b013e31826956f6","article-title":"Transcriptional profiling of rapamycin-treated fibroblasts from hypertrophic and keloid scars","volume":"72","author":"Wong","year":"2014","journal-title":"Ann Plast Surg"},{"key":"R69-20230814","doi-asserted-by":"crossref","first-page":"1340","DOI":"10.1038\/jid.2012.483","article-title":"Potent dual inhibitors of TORC1 and TORC2 complexes (KU-0063794 and KU-0068650) demonstrate in vitro and ex vivo anti-keloid scar activity","volume":"133","author":"Syed","year":"2013","journal-title":"J Invest Dermatol"},{"key":"R70-20230814","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1111\/j.1365-4632.2005.02633.x","article-title":"Treatment of keloids and hypertrophic scars with dermojet injections of bleomycin: a preliminary study","volume":"44","author":"Saray","year":"2005","journal-title":"Int J Dermatol"},{"key":"R71-20230814","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1006\/abbi.1994.1042","article-title":"Regulation of lysyl oxidase mRNA in dermal fibroblasts from normal donors and patients with inherited connective tissue disorders","volume":"308","author":"Yeowell","year":"1994","journal-title":"Arch Biochem Biophys"},{"key":"R72-20230814","first-page":"23","article-title":"Bleomycin in the treatment of keloids and hypertrophic scars by multiple needle punctures","volume":"27","author":"Espana","year":"2001","journal-title":"Dermatol Surg"},{"key":"R73-20230814","first-page":"151","article-title":"Doxorubicin-induced inhibition of prolidase activity in human skin fibroblasts and its implication to impaired collagen biosynthesis","volume":"50","author":"Muszynska","year":"1998","journal-title":"Pol J Pharmacol"},{"key":"R74-20230814","doi-asserted-by":"crossref","first-page":"1735","DOI":"10.1172\/JCI113265","article-title":"Doxorubicin-induced inhibition of prolyl hydroxylation during collagen biosynthesis in human skin fibroblast cultures. Relevance to imparied wound healing","volume":"80","author":"Sasaki","year":"1987","journal-title":"J Clin Invest"},{"key":"R75-20230814","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/S0014-2999(00)00847-5","article-title":"The mechanism for anthracycline-induced inhibition of collagen biosynthesis","volume":"411","author":"Muszynska","year":"2001","journal-title":"Eur J Pharmacol"},{"key":"R76-20230814","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/S1357-2725(96)00120-3","article-title":"Transforming growth factor beta s and wound healing","volume":"29","author":"O'Kane","year":"1997","journal-title":"Int J Biochem Cell Biol"},{"key":"R77-20230814","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1111\/j.1524-475X.2007.00320.x","article-title":"Site-specific production of TGF-beta in oral mucosal and cutaneous wounds","volume":"16","author":"Schrementi","year":"2008","journal-title":"Wound Repair Regen"},{"key":"R78-20230814","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1006\/jsre.1999.5580","article-title":"TGF-beta2 activates proliferative scar fibroblasts","volume":"82","author":"Smith","year":"1999","journal-title":"J Surg Res"},{"issue":"Suppl 1","key":"R79-20230814","doi-asserted-by":"crossref","first-page":"s38","DOI":"10.1111\/j.1524-475X.2011.00711.x","article-title":"Discovery and development of avotermin (recombinant human transforming growth factor beta 3): a new class of prophylactic therapeutic for the improvement of scarring","volume":"19","author":"Occleston","year":"2011","journal-title":"Wound Repair Regen"},{"key":"R80-20230814","doi-asserted-by":"crossref","first-page":"1264","DOI":"10.1016\/S0140-6736(09)60322-6","article-title":"Prophylactic administration of avotermin for improvement of skin scarring: three double-blind, placebo-controlled, phase I\/II studies","volume":"373","author":"Ferguson","year":"2009","journal-title":"Lancet"},{"key":"R81-20230814","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1097\/PRS.0b013e318217429b","article-title":"Avotermin for scar improvement following scar revision surgery: a randomized, double-blind, within-patient, placebo-controlled, phase II clinical trial","volume":"128","author":"So","year":"2011","journal-title":"Plast Reconstr Surg"},{"key":"R85-20230814","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1111\/1523-1747.ep12876204","article-title":"Epidermal and dermal effects of epidermal growth factor during wound repair","volume":"94","author":"Nanney","year":"1990","journal-title":"J Invest Dermatol"},{"key":"R86-20230814","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1097\/00000637-200110000-00010","article-title":"The ontogeny of scarless healing II: EGF and PDGF-B gene expression in fetal rat skin and fibroblasts as a function of gestational age","volume":"47","author":"Peled","year":"2001","journal-title":"Ann Plast Surg"},{"key":"R87-20230814","doi-asserted-by":"crossref","first-page":"1319","DOI":"10.1084\/jem.163.5.1319","article-title":"Enhancement of epidermal regeneration by biosynthetic epidermal growth factor","volume":"163","author":"Brown","year":"1986","journal-title":"J Exp Med"},{"key":"R88-20230814","doi-asserted-by":"crossref","first-page":"2258","DOI":"10.1002\/1097-0142(20001201)89:11<2258::AID-CNCR14>3.0.CO;2-Z","article-title":"The correlation between epidermal growth factor levels in saliva and the severity of oral mucositis during oropharyngeal radiation therapy","volume":"89","author":"Epstein","year":"2000","journal-title":"Cancer"},{"key":"R89-20230814","doi-asserted-by":"crossref","first-page":"589","DOI":"10.3346\/jkms.2010.25.4.589","article-title":"Effect of recombinant human epidermal growth factor against cutaneous scar formation in murine full-thickness wound healing","volume":"25","author":"Kim","year":"2010","journal-title":"J Korean Med Sci"},{"key":"R90-20230814","doi-asserted-by":"crossref","first-page":"159","DOI":"10.3109\/09546634.2014.906034","article-title":"Effect of recombinant human epidermal growth factor on cutaneous scar quality in thyroidectomy patients","volume":"26","author":"Shin","year":"2015","journal-title":"J Dermatolog Treat"},{"key":"R91-20230814","first-page":"1005","article-title":"Improvement in atrophic acne scars using topical synthetic epidermal growth factor (EGF) serum: a pilot study","volume":"14","author":"Seidel","year":"2015","journal-title":"J Drugs Dermatol"},{"key":"R92-20230814","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.pcad.2004.04.006","article-title":"Calcium antagonists","volume":"47","author":"Grossman","year":"2004","journal-title":"Prog Cardiovasc Dis"},{"key":"R93-20230814","doi-asserted-by":"crossref","first-page":"343","DOI":"10.4103\/0378-6323.42899","article-title":"Comparison of intralesional verapamil with intralesional triamcinolone in the treatment of hypertrophic scars and keloids","volume":"74","author":"Margaret Shanthi","year":"2008","journal-title":"Indian J Dermatol Venereol Leprol"},{"key":"R94-20230814","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1097\/00004630-199611000-00005","article-title":"The 1996 Lindberg Award. Calcium antagonists alter cell shape and induce procollagenase synthesis in keloid and normal human dermal fibroblasts","volume":"17","author":"Doong","year":"1996","journal-title":"J Burn Care Rehabil"},{"key":"R95-20230814","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1159\/000051812","article-title":"Prevention and treatment of keloids with intralesional verapamil","volume":"204","author":"D'Andrea","year":"2003","journal-title":"Dermatology"},{"key":"R96-20230814","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1097\/00000637-199608000-00008","article-title":"Treatment of earlobe keloids with surgery plus adjuvant intralesional verapamil and pressure earrings","volume":"37","author":"Lawrence","year":"1996","journal-title":"Ann Plast Surg"},{"issue":"Suppl 2","key":"R97-20230814","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1034\/j.1600-0625.12.s2.6.x","article-title":"Tretinoin reverses upregulation of matrix metalloproteinase-13 in human keloid-derived fibroblasts","volume":"12","author":"Uchida","year":"2003","journal-title":"Exp Dermatol"},{"key":"R98-20230814","doi-asserted-by":"crossref","first-page":"900","DOI":"10.1016\/S0190-9622(86)70248-X","article-title":"Retinoid effects on fibroblast proliferation and collagen synthesis in vitro and on fibrotic disease in vivo","volume":"15","author":"Daly","year":"1986","journal-title":"J Am Acad Dermatol"},{"key":"R99-20230814","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1001\/archderm.1985.01660050084020","article-title":"Retinoid modulation of connective tissue metabolism in keloid fibroblast cultures","volume":"121","author":"Abergel","year":"1985","journal-title":"Arch Dermatol"},{"key":"R100-20230814","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1111\/j.1365-2133.1980.tb07251.x","article-title":"The local treatment of hypertrophic scars and keloids with topical retinoic acid","volume":"103","author":"Janssen de Limpens","year":"1980","journal-title":"Br J Dermatol"},{"key":"R101-20230814","doi-asserted-by":"crossref","first-page":"1275","DOI":"10.1111\/j.1524-4725.1988.tb03483.x","article-title":"Retinoic acid in the treatment of keloids","volume":"14","author":"Panabiere-Castaings","year":"1988","journal-title":"J Dermatol Surg Oncol"},{"key":"R102-20230814","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1111\/jdv.12242","article-title":"Comparative effect of topical silicone gel and topical tretinoin cream for the prevention of hypertrophic scar and keloid formation and the improvement of scars","volume":"28","author":"Kwon","year":"2014","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"R103-20230814","first-page":"4359","article-title":"Tamoxifen inhibits angiogenesis in estrogen receptor-negative animal models","volume":"6","author":"Blackwell","year":"2000","journal-title":"Clin Cancer Res"},{"key":"R104-20230814","doi-asserted-by":"crossref","first-page":"2201","DOI":"10.1002\/1097-0142(19831215)52:12<2201::AID-CNCR2820521204>3.0.CO;2-#","article-title":"Remission of rapidly growing desmoid tumors after tamoxifen therapy","volume":"52","author":"Kinzbrunner","year":"1983","journal-title":"Cancer"},{"key":"R105-20230814","first-page":"502","article-title":"The response of retroperitoneal fibrosis to tamoxifen","volume":"109","author":"Clark","year":"1991","journal-title":"Surgery"},{"key":"R106-20230814","first-page":"718","article-title":"The inhibitory effect of tamoxifen on keloid fibroblasts","volume":"47","author":"Mancoll","year":"1996","journal-title":"Surg Forum"},{"key":"R107-20230814","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1054\/bjps.1997.0100","article-title":"Topical tamoxifen\u2014a potential therapeutic regime in treating excessive dermal scarring?","volume":"51","author":"Hu","year":"1998","journal-title":"Br J Plast Surg"},{"key":"R108-20230814","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1001\/archfaci.3.2.111","article-title":"Effect of tamoxifen on transforming growth factor beta1 production by keloid and fetal fibroblasts","volume":"3","author":"Mikulec","year":"2001","journal-title":"Arch Facial Plast Surg"},{"key":"R109-20230814","first-page":"372","article-title":"Uso do tamoxifeno no tratamento de queloides e cicatrizes hipertroficas","volume":"25","author":"Pasquetti","year":"2010","journal-title":"Rev Bras Cir Plast"},{"key":"R110-20230814","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1007\/s00266-009-9334-z","article-title":"Treatment of hypertrophic scars with intralesional botulinum toxin type A injections: a preliminary report","volume":"33","author":"Xiao","year":"2009","journal-title":"Aesthetic Plast Surg"},{"key":"R111-20230814","doi-asserted-by":"crossref","first-page":"1128","DOI":"10.1016\/j.bjps.2008.05.003","article-title":"Botulinum toxin type A affects cell cycle distribution of fibroblasts derived from hypertrophic scar","volume":"61","author":"Zhibo","year":"2008","journal-title":"J Plast Reconstr Aesthet Surg"},{"key":"R112-20230814","doi-asserted-by":"crossref","first-page":"275e","DOI":"10.1097\/PRS.0b013e3181b98ee7","article-title":"Intralesional botulinum toxin type A injection as a new treatment measure for keloids","volume":"124","author":"Zhibo","year":"2009","journal-title":"Plast Reconstr Surg"},{"key":"R113-20230814","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1159\/000342125","article-title":"Botulinum toxin A for the treatment of keloids","volume":"25","author":"Gauglitz","year":"2012","journal-title":"Skin Pharmacol Physiol"},{"key":"R114-20230814","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1016\/j.bjps.2012.08.042","article-title":"Keloid scars and treatment with botulinum toxin type A: the Belfast experience","volume":"66","author":"Robinson","year":"2013","journal-title":"J Plast Reconstr Aesthet Surg"},{"key":"R115-20230814","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1097\/00006534-200207000-00029","article-title":"Effect of Mederma on hypertrophic scarring in the rabbit ear model","volume":"110","author":"Saulis","year":"2003","journal-title":"Plast Reconstr Surg"},{"key":"R116-20230814","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1159\/000246625","article-title":"Effects of various growth factors and histamine on cultured keloid fibroblasts","volume":"190","author":"Kikuchi","year":"1995","journal-title":"Dermatology"},{"key":"R117-20230814","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1007\/BF02285158","article-title":"The role of mast cell-derived histamine in the closure of an in vitro wound","volume":"45","author":"Kupietzky","year":"1996","journal-title":"Inflamm Res"},{"key":"R118-20230814","first-page":"1507","article-title":"An open, randomized, controlled, comparative study of the combined effect of intralesional triamcinolone acetonide and onion extract gel and intralesional triamcinolone acetonide alone in the treatment of hypertrophic scars and keloids","volume":"34","author":"Koc","year":"2008","journal-title":"Dermatol Surg"},{"key":"R119-20230814","doi-asserted-by":"crossref","first-page":"251","DOI":"10.12968\/jowc.2007.16.6.27070","article-title":"The effects of onion extract on hypertrophic and keloid scars","volume":"16","author":"Hosnuter","year":"2007","journal-title":"J Wound Care"},{"key":"R120-20230814","first-page":"468","article-title":"Advances in the treatment of keloids","volume":"10","author":"Viera","year":"2011","journal-title":"J Drugs Dermatol"},{"key":"R121-20230814","doi-asserted-by":"crossref","first-page":"828","DOI":"10.1016\/j.jaad.2013.06.025","article-title":"A novel hydrogel scaffold for the prevention or reduction of the recurrence of keloid scars postsurgical excision","volume":"69","author":"Berman","year":"2013","journal-title":"J Am Acad Dermatol"},{"key":"R122-20230814","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1038\/nm.2574","article-title":"Focal adhesion kinase links mechanical force to skin fibrosis via inflammatory signaling","volume":"18","author":"Wong","year":"2012","journal-title":"Nat Med"},{"key":"R123-20230814","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1097\/PRS.0000000000000417","article-title":"A randomized controlled trial of the embrace advanced scar therapy device to reduce incisional scar formation","volume":"134","author":"Longaker","year":"2014","journal-title":"Plast Reconstr Surg"},{"key":"R124-20230814","first-page":"825","article-title":"Updated international clinical recommendations on scar management: part 2\u2014algorithms for scar prevention and treatment","volume":"40","author":"Gold","year":"2014","journal-title":"Dermatol Surg"}],"container-title":["Dermatologic Surgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/00042728-201701001-00002","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,8,14]],"date-time":"2023-08-14T15:04:30Z","timestamp":1692025470000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00042728-201701001-00002"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,1]]},"references-count":118,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2017]]}},"URL":"https:\/\/doi.org\/10.1097\/dss.0000000000000819","relation":{},"ISSN":["1076-0512","1524-4725"],"issn-type":[{"value":"1076-0512","type":"print"},{"value":"1524-4725","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,1]]}}}